A fibroblast-rich transcriptomic axis reflects stromal remodeling within the CMS4 phenotype in colorectal cancer
- 1Zhejiang University
Abstract
Bulk-tumor expression signatures can reflect cellular composition as well as tumor-cell programs. We evaluated a frozen, equal-weight 87-gene score in colorectal cancer using 11 Gene Expression Omnibus (GEO) cohorts, TCGA COAD/READ, and E-MTAB-12862. In GEO (1,783 tumors; 441 progression-related events), the hazard ratio per score standard deviation was 1.33 (95% confidence interval, 1.19-1.49). The estimate was similar in seven disease-free-survival cohorts. In 376 TCGA tumors, the hazard ratio was 1.25 (1.03-1.52) for progression-free interval. The association did not reproduce in E-MTAB-12862: among 948 stage I-III tumors with 436 recurrence-free-survival events, the hazard ratio was 1.05 (0.95-1.16). The frozen score correlated with CMS4, cancer-associated fibroblast, and stromal measures. The stromal-remodeling module produced a GEO estimate similar to the full score, whereas removing that module attenuated the association. Composition residualization did not detect additional prognostic information after accounting for the measured CMS4 and stromal components. Single-cell and spatial analyses localized the gene program to fibroblast-rich compartments. The 87-gene score mainly reflects a fibroblast-rich, matrix-remodeling component of CMS4 rather than an independent prognostic subtype. Its prognostic association varied across cohorts, and current evidence does not support clinical use.
Related
- Cross-cohort single-nucleus transcriptomic identification of a MEOX1+FAP+ACTA2-low extracellular matrix-remodeling fibroblast state in dilated cardiomyopathy
- Single-cell transcriptomic analysis reveals fibroblast state-specific remodeling of purinergic signaling in diabetic gingiva
- Adverse Graft Remodeling Reflects Dynamic Allograft Stress and Predicts Adverse Outcomes After Heart Transplantation
- Integrated scRNA‐Seq and Spatial Transcriptomics Reveal CHPF and GPC1 as Markers of Cancer‐Associated Fibroblast–Dominant Domains in Colorectal Cancer
- Early Fibroblast Remodeling Associated with Lung Tissue Preservation After FLASH Irradiation.
BibTeX
@misc{zheng2026fibroblastrich,
title = {{A fibroblast-rich transcriptomic axis reflects stromal remodeling within the CMS4 phenotype in colorectal cancer}},
author = {Y. Zheng and S. Hao and C. Jiang},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.18.752659},
url = {https://www.biorxiv.org/content/10.64898/2026.09.18.752659v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - A fibroblast-rich transcriptomic axis reflects stromal remodeling within the CMS4 phenotype in colorectal cancer
AU - Y. Zheng
AU - S. Hao
AU - C. Jiang
PY - 2026
DA - 2026/09/18
PB - bioRxiv
DO - 10.64898/2026.09.18.752659
UR - https://www.biorxiv.org/content/10.64898/2026.09.18.752659v1
AB - Bulk-tumor expression signatures can reflect cellular composition as well as tumor-cell programs. We evaluated a frozen, equal-weight 87-gene score in colorectal cancer using 11 Gene Expression Omnibus (GEO) cohorts, TCGA COAD/READ, and E-MTAB-12862. In GEO (1,783 tumors; 441 progression-related events), the hazard ratio per score standard deviation was 1.33 (95% confidence interval, 1.19-1.49). The estimate was similar in seven disease-free-survival cohorts. In 376 TCGA tumors, the hazard ratio was 1.25 (1.03-1.52) for progression-free interval. The association did not reproduce in E-MTAB-12862: among 948 stage I-III tumors with 436 recurrence-free-survival events, the hazard ratio was 1.05 (0.95-1.16). The frozen score correlated with CMS4, cancer-associated fibroblast, and stromal measures. The stromal-remodeling module produced a GEO estimate similar to the full score, whereas removing that module attenuated the association. Composition residualization did not detect additional prognostic information after accounting for the measured CMS4 and stromal components. Single-cell and spatial analyses localized the gene program to fibroblast-rich compartments. The 87-gene score mainly reflects a fibroblast-rich, matrix-remodeling component of CMS4 rather than an independent prognostic subtype. Its prognostic association varied across cohorts, and current evidence does not support clinical use.
ER -